000			01995 a2200577 4500
005			20250516153118.0
264		0	_c20140414
008			201404s 0 0 eng d
022			_a1948-7193
024	7		_a10.1021/cn400116z _2doi
040			_aNLM _beng _cNLM
100	1		_aNiphakis, Micah J
245	0	0	_aEvaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors. _h[electronic resource]
260			_bACS chemical neuroscience _cSep 2013
300			_a1322-32 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAmidohydrolases _xantagonists & inhibitors
650	0	4	_aAnimals
650	0	4	_aBlood Glucose _xanalysis
650	0	4	_aBrain _xdrug effects
650	0	4	_aCarbamates _xchemical synthesis
650	0	4	_aDiabetes Mellitus, Type 2 _xblood
650	0	4	_aDiabetic Neuropathies _xblood
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aEndocannabinoids _xmetabolism
650	0	4	_aHEK293 Cells
650	0	4	_aHumans
650	0	4	_aHyperalgesia _xdrug therapy
650	0	4	_aInsulin _xblood
650	0	4	_aLiver _xdrug effects
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMolecular Structure
650	0	4	_aMonoacylglycerol Lipases _xantagonists & inhibitors
650	0	4	_aNociception _xdrug effects
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aSpecies Specificity
650	0	4	_aStructure-Activity Relationship
650	0	4	_aSuccinimides _xchemistry
700	1		_aCognetta, Armand B
700	1		_aChang, Jae Won
700	1		_aBuczynski, Matthew W
700	1		_aParsons, Loren H
700	1		_aByrne, Frederika
700	1		_aBurston, James J
700	1		_aChapman, Victoria
700	1		_aCravatt, Benjamin F
773	0		_tACS chemical neuroscience _gvol. 4 _gno. 9 _gp. 1322-32
856	4	0	_uhttps://doi.org/10.1021/cn400116z _zAvailable from publisher's website
999			_c22802780 _d22802780